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Mercury poisoning cases have been reported in many parts of the world, resulting in many deaths every year.
Mercury compounds are classified in different chemical types such as elemental, inorganic and organic forms. Long
term exposure to mercury compounds from different sources e.g. water, food, soil and air lead to toxic effects on
cardiovascular, pulmonary, urinary, gastrointestinal, neurological systems and skin. Mercury level can be measured in
plasma, urine, feces and hair samples. Urinary concentration is a good indicator of poisoning of elemental and
inorganic mercury, but organic mercury (e.g. methyl mercury) can be detected easily in feces. Gold nanoparticles
(AuNPs) are a rapid, cheap and sensitive method for detection of thymine bound mercuric ions. Silver nanoparticles
are used as a sensitive detector of low concentration Hg2+ ions in homogeneous aqueous solutions. Besides
supportive therapy, British anti lewisite, dimercaprol (BAL), 2,3-dimercaptosuccinic acid (DMSA. succimer) and
dimercaptopropanesulfoxid acid (DMPS) are currently used as chelating agents in mercury poisoning. Natural
biologic scavengers such as algae, azolla and other aquatic plants possess the ability to uptake mercury traces from
the environment.
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Mercury (Hg) atomic number 80, is a liquid metal at room
temperature and pressure. Mercury freezes at -38.9°C and
boils at 357°C. It is sometimes called quick silver and is
easily alloyed with many other metals, such as gold, silver
and tin [1]. It exists in the environment in three forms:
elemental mercury (poisonous as vapor), organic mercury
(methyl mercury and ethyl mercury) and inorganic mer-
cury (mercuric mercury) and all these forms have toxic
health effects [2].
In recent years, due to abundant availability of various
chemicals, the rate of intoxication has been surprisingly
increased [3,4]. People can overuse or misuse drugs, che-
micals, and may get poisoned intentionally or acciden-
tally [5,6]. Similarly, heavy metals, either released from
natural sources or from industries wastes pose a consis-
tent health threat to human being [7].* Correspondence: moghadamnia@yahoo.com
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[8]. Mercury and its related compounds are being circu-
lated and concentrated in soil and distributed into the
air via coal fuels, industrial furnaces or active volcanoes.
It then returns to the soil, water, or living organisms. Re-
cycling from atmospheric emission, deposition in water
reservoirs and exposure and bioaccumulation in animals
and humans is a known example of mercury cycle in the
environment [9] (see Figure 1).
Epidemiology
Humans exposure to mercury usually take place via eat-
ing mercury contaminated food, dental care procedures
(using amalgams in endodontics) using mercury based,
thermometers, and sphygmomanometer), occupational
exposure (e.g. mining) and others (using fluorescent light
bulbs and batteries) [10].
Metallic mercury intoxication was known in ancient
times by Aristotle, but that large scale occupational poi-
soning with mercury had occurred when the great statue
of Buddha of Nara was constructed in 8th century in
Japan [11].ed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 Schematic view of mercury environmental recycling from the atmospheric emission, deposition, exposure and bioaccumulation,
Hg [0]: (elemental mercury), Hg [II]: (inorganic mercury) and CH3Hg [II] (retrieved with permission from: [9].
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had been reported. The first, Minamata disease; poiso-
ning of 2200 peoples due to consumption of mercury
contaminated fishes and shell fish in Kyushu Japan. Also
other cases of mercury intoxication had been reported in
Niigata (the main island of Honshu, Japan) with appro-
ximately 700 victims, during 1950,s and 1960,s [9,12-14].
The third, three epidemics of mercury poisoning cases
have been reported in Iraq during 1955-1956, 1959-1960,
and largest outbreak in 1971-1972 in the rural population
following the consumption of mercury contaminated ho-
memade. Based on official reports, 6530 patients were
hospitalized and 459 persons died [13,14].
There is a serious concern of environmental pol-
lution following handling of mercury compounds, for
example; dumping inorganic mercury along the Amazon
River in Brazil, pit-working in gold mines in Tanzania,
Indonesia, and the Philippines, Ecuador, Faroe islands,
French Guiana, New Zealand, Peru, Seychelles island and
Slovenia [15,16].
Some sea foods e.g. tuna fish may concentrate mercury
compounds and its chronic use may cause poisoning.
Similarly, in coastal provinces of Iran (e.g. Khuzestan)
[17-19] mercury compounds have been reported in tap
and agricultural water sources in Shiraz and Mashhad,
two populous cities in Iran [20,21]. Persian Gulf and
Caspian Sea are the main seafood sources in Iran. Al-
though, mercury concentration in marginal countries ofCaspian Sea except the Republic of Azerbaijan and with
coast line of the Persian Gulf and Oman Sea are gener-
ally quite low by international standard, but large con-
sumption pattern may result in increased health risks
[22-24].
According to recent studies it has been shown that
mercury vapors from handling of amalgam, can be haz-
ardous for dental staffs [25,26].
Mercury poisoning is a known topic in various regions
of the world, but the incidence of new cases of poisoning
in Iran has created an opportunity to reconsider to this
silent threat.
Governmental and nongovernmental organizations
should prepare basic data about mercury poisoning and
design informative and educational programs on mercury
poisoning in order to substantially reduce the incidence of
poisoning with mercury. This review can be helpful in
achieving the purpose to manage the various aspects of
poisoning by mercury compounds.
Mechanisms of toxicity
Mercury compounds exert toxic health effects by differ-
ent mechanisms such as; interruption of microtubule
formation, changing intracellular calcium balance and
membrane potential, altering cell membrane integrity,
disturbing or inhibition of enzymes, inducing oxidative
stress, inhibition of protein and DNA synthesis and dis-
turbing immune functions [27].
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groups in biological molecules [28]. Methyl mercury in-
duces oxidative stress and the free radicals may cause
neurotoxicity. On the other hand, it has been reported
that accumulation of serotonin, aspartate, and glutamate
has a role in mechanism of methyl mercury induced-
neurotoxicity [29].
Methyl mercury is converted to inorganic form in
CNS that binds to sulfhydryl-containing molecules. In-
organic mercury and methyl mercury bind to thiol-
containing protein e.g. glutamine, cysteine, albumin and
etc. These complexes affect the distribution of mercury
in the body [30].
Binding to endogenous thiol-groups facilitate the dis-
tribution of mercury compounds in the body. It also
protects the compounds from binding to other proteins,
thus providing a protective mechanism [31].
Clinical manifestations
Different forms of mercury compounds have different
clinical manifestations and adverse effects that will be
explained in the details below.
Elemental mercury
Inhaling elemental mercury vapors causes acute symp-
toms such as cough, chills, fever, and shortness of breath,
and also GIT complaints such as nausea, vomiting and
diarrhea accompanied by a metallic taste, dysphagia, sa-
livation, weakness, headaches and visual disorders [28].
Long-term inhalation of elemental mercury may cause
cognitive impairment including decreased performance
intellectual functioning, impairments of attention and
short term memory, visual judgment of angles and direc-
tions, psychomotor retardation and personality changes
including depression and willing to be alone, anxiety and
lack of sensitivity to physical stimuli [32]. Whenever elem-
ental or metallic mercury is ingested, it rarely confronts to
clinical consequences in normal GIT mucosa. However,
people having abnormal GIT mucosa absorb enough ele-
mental mercury during exposure, producing severe irri-
tation [2]. Corrosive injuries will start immediately after
mercuric salts ingestion. Oral cavity problems such as in-
flammation of the mouth, ulcerative gingivitis, loose teeth,
gingival bleeding and metallic taste may be observed [33].
Also, a grayish discoloration of mucous membranes, nau-
sea, vomiting, local oropharyngeal pain, bloody diarrhea
may be seen. Released mercury from dental amalgams
may even induce stomatitis [34,35].
Elemental mercury crosses the alveolar membrane du-
ring respiration and readily absorbs into blood, and then
distributed and transferred into the tissues [36]. The
clinical manifestations of intoxication include: chest pain,
dyspnea, dry cough, hypoxemia and altered carbon mon-
oxide diffusing capacity and ventilatory patterns [37].Mercury vapor at higher concentrations have caused nec-
rotizing bronchitis, bronchiolitis and pneumonitis. It can
also progress to pulmonary edema, respiratory failure and
death. Complications include multiple pneumothoraces,
pneumomediastinum, and subcutaneous emphysema [38].
In survivors, severe pulmonary complication like; intersti-
tial fibrosis and residual restrictive pulmonary diseases
may be developed [28]. Subcutaneous injection of a solu-
tion containing metallic mercury may cause local abscess
and granuloma formations. IV (intravenous) injection
cause acute pulmonary embolism and systemic micro-
embolism with respiratory failure [38].
Inorganic mercury
In acute cases ingestion of inorganic mercury salts cause
gastroenteritis. The color of mucous membranes changes
rapidly along with development of metallic taste, local
oropharyngeal pain, nausea, vomiting, bloody diarrhea,
colic abdominal pain and renal dysfunction [15].
Subsequently, stomatitis, hematemesis, and hemato-
chezia may be seen, chronic inorganic mercury salts in-
toxication may lead to development of tremor of the
lips, tongue, severe salivation, losing teeth, anorexia, and
weight loss [28,39].
In addition to salivation, gingivitis, gingival bleeding,
oral stomatitis, corrosive damage to the mouth and throat
have also been observed. The symptoms of acute inor-
ganic mercury inhalation include dyspnea, chest pain,
tightness, and dry cough, which are followed by acute
chemical pneumonitis and bronchiolitis. Another clinical
manifestation is shock that causes to massive fluid loss,
and acute tubular necrosis. The predominant manifesta-
tions of sub-acute or chronic mercury intoxication include
GI symptoms, neurologic abnormalities and renal dys-
function [15,28,39].
The first visible lesion of atherosclerosis in arterial wall
is the fatty streak or the foam cell. These cells penetrate
into the sub-endothelial space. This penetration can pre-
dispose uptake and storage cholesterol, and may result
in atherogenesis [40]. Oxidation of LDL in the arterial
intima has an important role in athrogenesis. Oxidized
LDL increases pro-inflammatory genes expression that
causes to aggregate monocyte in the vessels wall and
may induce vessel dysfunction. This behaves to generate
free radicals [41]. Mercury compounds catalyze peroxi-
dation, e.g. mercuric chloride increases hydrogen perox-
ide formation and depletes glutathione. This process is
increased at the risk of coronary heart disease [42]. The
clinical finding of mercury toxicity include coronary heart
disease (CHD), myocardial infarction (MI), increases in
carotid intimal medial thickness (IMT), carotid obstruc-
tion and hypertension [43].
When inorganic mercury compounds are absorbed into
bloodstream, the highest concentration (about 85-90%) is
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and accumulated in the proximal tubules of the kidneys
[44,45]. Clinical findings are polyuria and proteinuria
(especially low molecular proteinuria) which are the main
indicators of tubular damage in kidneys. In severe
conditions, patients suffer from nephrotic syndrome with
hematuria and anuria [44]. Chronic inorganic mercury ex-
posure can cause immune complex nephritis, especially
membranous nephropathy [46]. In humans, long term ex-
posure to mercury has been accompanied with immu-
nological glomerular diseases which is responsible for
mercury-induced nephropathy [47].
Organic mercury
In mild exposure, organic mercury compounds espe-
cially methyl mercury do not produce severe symptoms,
but high exposure to organic mercury compounds leads
to acute GIT symptoms and delayed neurotoxicity, re-
gional destruction of neurons [28,48]. Ethyl mercury is
rapidly metabolized into inorganic mercury that can in-
duce nephrotoxicity [49]. CNS manifestation including
autism syndrome which may appear after ethyl mercury
intoxication [50,51]. Poisoning with organic mercury
often occurs after eating some sea food containing mer-
cury. Organic mercury is divided into three forms; aryl,
short chain alkyl, and long chain alkyl compounds. Aryl
and long chain alkyl have similar properties to inorganic
mercury toxicity, but they are slightly corrosive (organic
mercury is less corrosive than inorganic mercury)
[33,52]. Also, in contaminated areas, most of the fresh
water and salt water fish contain methyl mercury and
this agent has acute GI symptoms, in which the above
subjects have been pointed out [52].
Toxic effects on CNS
Toxic effects of mercury compounds on the human cen-
tral nervous system are well known and in experimental
animals it has been shown that mercury cross the pla-
centa and reach fetal brain and get accumulated in the
CNs and subsequent neurological disturbance occur in
fetus [53,54].
Toxic effects on skin
Mercury compounds show toxic effects on the skin in
many ways. Most common symptoms of contact derma-
titis after exposure to mercury compounds include mild
swelling, vesiculation, scaling, irritation, urticaria and
erythema. Allergic contact dermatitis accompanied by
pain, is the most important form of mercurial reaction
in skin that can occur by both topical and systemic ex-
posure [34]. In case of injection these mucocutaneous
hyperpigmentation results and also purpura may be seen
in advanced stage [34,35].Diagnostic evaluation
Mercury exists in several physical and chemical statuses
and may undergo biotransformation. In clinical labora-
tories, mercury levels in blood and urine are often deter-
mined as the total mercury, without paying attention to
the physical and chemical forms [55].
Urine
Urine is a good sample for assaying elemental and in-
organic mercury. Quantity more than 100 μg/L, pro-
duce neurological signs while concentration greater than
800 μg/L are often associated with death. Organic mer-
cury such as methyl mercury is excreted mainly in feces,
so the urine sample test is not a reliable indicator of the
level of organic mercury in the body [56].
Blood
In acute intoxication, concentration of methyl mercury
in red blood cells is high, but it varies in chronic toxicity.
The whole blood mercury concentration is often less
than 10 μg/L, but it normally may reach to 20 μg/L. After
long term exposure to mercury vapors, the blood mercury
concentration may be increased to 35 μg/L [27].
Hair and nail
Hair has high sulfhydryl groups and mercury compounds
have high tendency to bind sulfur. After exposure to me-
thyl mercury, total mercury levels in hair and blood will
be used as biomarkers to evaluate the extent of poisoning.
Hair: blood ratio in human is 250:1 [57]. It may be noted
that hair analysis should not be used alone for confirming
mercury exposure or its toxicity. In general, mercury con-
centrations in the hair do not exceed 10 mg/kg. In moder-
ate intoxications, hair mercury concentration is in the
range of 200-800 mg/kg but in severe case it may reach to
2400 mg/kg. WHO has advised monitoring of hair levels
of methyl mercury in pregnant women and the con-
centrations equal or greater than 10 ppm increase the
risk of neurological deficits in the next generation [33].
Meanwhile, the Methyl mercury easily crosses the blood-
placenta barrier and accumulates more in the fetus than
the mother. Methyl mercury binds to hemoglobin, its con-
centration in cord blood is higher than mother’s blood.
The umbilical cord is formed and developed mainly in the
second and third trimesters. Both inorganic and methyl
mercury are detected in the regular analysis of total mer-
cury concentration, but the methylated form of mercury is
detected in cord blood. Based on this result, the National
Research Council (NRC) recommended the cord blood
mercury concentration as the best available biomarker for
fetal exposure to methyl mercury [58,59]. According to
Brockman et al. [60] report the Hg/Selenium molar ratio
is suggested to assess methyl mercury exposures in rats’
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eously be used to evaluate methyl mercury exposures [60].
Application of nano-medicine in the diagnosis of mercury
poisoning
Nanotechnology has revolutionized drug and medical
sciences. This technology can cover a wide spread appli-
cation such as tissue, cell and gene structures, medical
instruments and tools, drugs delivery [61] and in bio-
medical researches, diagnosis evaluations and treatments
[62]. Efficient methods have been presented in the litera-
ture regarding diagnosis of mercury poisoning. The use
of gold nanoparticles (AuNPs) which is a rapid, cheap
and sensitive detection method. This method detect
DNA and RNA sequences [63,64]. Some studies have
reported that Hg2+ bind thymine (thymine-mercury-
thymine). This interaction may form base pairs in DNA.
These bases are absorbed onto AuPNs surfaces. This
combination develops Hg2+ sensors, based on the func-
tion of DNA and lysozyme gold. After the combinations
of DNA with gold nanoparticles, then Hg2+ is detected
by colorimetric sensors [63].
Silver nanoparticles (AgNPs) have been used as anti-
bacterial, sunscreens and cosmetic agents. Also, AgNPs
have been used as a biosensor or sensitive detector of
low concentration Hg2+ ions in homogeneous aque-
ous solutions [65]. On the other hand, ultrasensitive
surface-enhanced Raman scattering (SERS) nanosensor
developed for mercury ion (Hg2+) detection based on
4-mercaptopyridine (4-MPY) functionalized silver nano-
particles (AgNPs) (4-MPY-AgNPs) in the presence of
spermine [66]. This reagent determine mercury up to
0.34 nM. Other Sensors for Mercury (Hg, HgI, HgII)
determine concentration levels up to parts-per-billion
[67,68].
Other diagnostic evaluation
Diagnostic tests depend on the clinical situation that
includes: complete blood cell count, electrolytes assay,
renal and liver function tests initially in acute elemental
mercury vapor. Chest X ray (CXR) may show interstitial
or alveolar abnormalities. Thereafter, acute respiratory
distress syndrome (ARDS) may appear. Other diagnostic
procedures are electrocardiography (ECG), pulmonary
function test (PFT), cardiovascular monitoring, electro-
neuromyography and neuropsychologic tests [27].
Treatment of mercury poisoning
Immediate considerations and decontamination
Monitoring of vital organs is needed in primary manage-
ment of acute exposure to elemental mercury vapors.
Supplemental oxygen or endotracheal intubation and
mechanical ventilation are recommended [38]. After pul-
monary aspiration bronchial lavage must not be done,because the particles of mercury can disperse further
into the lungs and the level of absorption may increase.
Chest X-rays determine the extent of dispersion. The
small mercury droplets are absorbed faster than the big-
ger ones [39]. In acute ingestions of inorganic mercury,
vascular access for IV fluid replacement is required to
prevent shock. Inorganic mercury produces severe cor-
rosive injuries. For corrosive injury, endoscopic examin-
ation is needed because it causes oropharyngeal edema
and upper airway obstruction. To overcome obstruction
of the airway, IV fluid therapy and endotracheal intub-
ation and/or tracheostomy are needed [38,39]. The skin
should be washed with soap and water in case of direct
contact with mercury.
Gastrointestinal decontamination should be implemen-
ted for inorganic mercury salt because of systemic absorp-
tion, but the important problem is the corrosive property
of these compounds. In spite of the corrosiveness of inor-
ganic mercury and the risk for perforation, the removal of
inorganic mercury is still beneficial. Whole-bowel irriga-
tion with polyethylene glycol solution may be useful for
removing residual mercury. Serial abdominal radiogra-
phies are needed to follow -up of the patients [28]. Ac-
tivated charcoal (AC) may be used but its efficacy is
controversial in case of mercury poisoning. The usual
oral dose of AC is 0.5-1 gr/kg, with a maximum dose
of 100 gr [69]. Many organic and inorganic contaminants
are removed with this method [70]. It is believed that AC
has been used to absorb different agents, except hydrocar-
bons, acids-alkalis, ethanol and heavy metal. Unlike in the
cases of heavy metal poisoning, charcoal tightly binds with
metallic compounds [38,69].Chelating agents
Penicillamine
It is a white crystalline, water-soluble derivative of peni-
cillin. D-penicillamine (DPA) is preferred to L isomer,
because DPA is less toxic than the L isomer [71]. D-
penicillamine is the drug of choice in Wilson’s disease,
and also useful in the management of other heavy metal
toxicity [72].
Penicillamine increase urinary excretion of lead and
mercury. The dosage schedule of DPA is: adults 250 mg
qid, po, for 1-2 weeks, children 20-30 mg/kg/daily in 4
divided doses (maximum 250 mg/dose). D-penicillamine
is only used for elemental and inorganic mercury tox-
icity and is not useful for organic mercury toxicity [73].
Hypersensitivity and nephrotoxicity are the most com-
mon adverse effects of penicillamine [71]. N-acetyl-d, l,
penicillamine (NAP) is an analog of DPA, that it is more
effective chelator of mercury. Recently succimer has
replaced penicillamine, because of its strong metal-
mobilizing capacity and lower side-effects [27,71].
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Since more than 60 years, BAL has been prescribed by
physicians for the treatment of heavy metal poisonings,
both accidental and iatrogenic. During World War II,
BAL decreased the risk of damage or death of the allied
soldiers. In 1951, BAL was applied to treat Wilson’s dis-
ease. Nowadays, BAL is one of the prominent drugs used
in the management of heavy metals poisoning [74]
(Figure 2).
In poisoning cases with elemental and inorganic mer-
cury salts, dimercaprol (BAL) may be administered 5
mg/kg IM once, 2.5 mg/kg IM every 8 to12 hours for
1 day, and then 2.5 mg/kg IM every 12 to 24 hours for
7 days [38]. Dimercaprol is ineffective and it may even
increase mercury levels in the brain and aggravate CNS
symptoms in case of organic mercury poisoning [75].
The common side effects of dimercaprol include nausea,
vomiting, hypertension, tachycardia, pain at the injection
site, headache, diaphoresis and convulsions [38].
Meso 2,3-dimercaptosuccinic acid (Succimer,DMSA)
It is a water-soluble analog of BAL, with chemical
formula C4H6O4S2, approved by FDA in 1991. Meso
2,3-dimercaptosuccinic acid inhibit activity of sulfhydryl-
containing enzymes and prevents mercury induced symp-
toms [71,76]. In humans, DMSA is rapidly metabolized
and excreted via urine and a small amount via bile and
lungs [77]. In the United States, BAL or DMSA is pre-
ferred for treatment of inorganic mercury poisoning [28].
WHO recommends that DMSA should be started in chil-
dren with urine mercury levels equal or greater than
50 μg/mL creatinine, if they are even asymptomatic [78].
DMSA has a half-life of 3.2 h [77].
DMSA is given via oral administration or IV injection.
Adult doses are 10 mg/kg tid for the first 5 days, then
10 mg/kg bid for the next 14 days. Children dose is
calculated based on the body surface area (BSA),
350 mg/m2tid for the first 5 days, then 350 mg/m2 bid
for the next 14 days. If necessary, it may be repeated,Figure 2 Chemical formula of BAL and their analogs meso-2,3-Dimerc
acid (DMPS).with a 2- week interval between treatments [38]. The
dimercapto chelating agents are least toxic. But in some
patients, neutropenia has been reported, therefore CBC,
renal and hepatic functions should be checked before
starting and during the treatment. The side effects of
DMSA include GI disorders, skin rashes and flu-like
symptoms [77].
2,3-dimercapto-1-propane sulfonic acid (Unithiol, DMPS)
It is a water-soluble analog of the dimercaprol with
chemical formula C3H7O3S3Na,. It has been approved
for use in Russia and other former Soviet countries since
1958, in Germany since 1976, and in the USA since
1999 [71,76]. It has replaced DMSA in Europe [28]. In
the body, DMPS is oxidized to disulfide forms. At least
80% of DMPS is oxidized within the first 30 minute. Ap-
proximately, 84% of total DMPS is excreted by the renal
system. It reduces the renal mercury burden when it en-
ters the renal tubular cells [79]. DMPS penetrates into
the kidney cells, and removes the mercury accumulated
in renal tissues and excrete mercury into the urine.
Based on clinical and experimental evidences, it has
been shown that DMPS remove mercuric mercury de-
posits in human tissues except brain [76,77]. All of the
complexes of inorganic mercury and chelating agents
are excreted via renal system [80].
DMPS is given either orally or IV injection. The adult
dose is: 250 mg IV every 4 hours for the first 48 hours is
administered, then 250 mg IV every 6 hours for the sec-
ond 48 hours and next 250 mg IV every 8 hours. After
IV administration, oral therapy may be started with
300 mg tid for 7 weeks. Duration of treatment depends
on the concentration of mercury in blood and urine.
Side effects are rare but, rash, nausea, and leucopenia
may be observed [38].
New DMSA analogues
Recently, many studies have shown that esters of DMSA
may be more effective antidotes for heavy metal poisoning.aptosuccinic acid (DMSA) and 2,3 Dimercapto-1-propanesulfonic
Figure 3 Chemical formula of MiADMSA (mono isoamyl ester
ofdimercaptosuccinic acid).
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can enhance tissue elimination of mercury [81]. DMSA
removes mercury both from the kidneys and bile. Its sulf-
hydryl group binds very tightly to mercury [82]. DMSA
has hydrophilic and lipophobic properties. It cannot pass
through cell membrane. Mono isoamyl ester of DMSA
(MiADMSA) is a water-soluble lipophilic chelating agent
and it is C5 branched chain ester (Figure 3). It may be a
more effective chelating agent for reducing lead, mercury
and cadmium burden [83]. MiADMSA can penetrate to
intracellular space and has an extensive cellular distribu-
tion. It removes heavy metals from both intra and extra
cellular sites [84].
MiADMSA can decrease the oxidative stress in tissue
by two ways. First, it removes the heavy metal from the
target organ and second, it scavenges ROS (reactive oxy-
gen species) via sulfhydryl groups [84]. Heavy metalsFigure 4 New monoesters of dimercaptosuccinic acid (DMSA).such as mercury, lead and selenium have a high affinity
for sulfhydryl groups [85]. MiADMSA has lipophilic prop-
erty and its molecular size may allow removing heavy
metals and producing better therapeutic efficacy [83]. It is
administrated via oral and intraperitoneal route at doses
25,50 and 100 mg/kg. Although, based on histopatholo-
gical studies of liver and kidneys in experimental animals,
oral administration has been found better than intraperi-
toneal injection [81].
Other new DMSA analogous are Monomethyl DMSA
(MmDMSA) and Monocyclohexyl DMSA (MchDMSA).
MmDMSA has a straight and branched chain of methyl
groups, whereas MchDMSA has a cyclic carbon chain
(Figure 4). Both are lipophilic and penetrate into cells.
Both of them are chelating agents and are administrated
through oral route. However, more studies are required
to evaluate their efficacy [86].
Combination therapy with chelating agents
Nowadays, one of the main subjects in the treatment of
heavy metal toxicity is the combination therapy. Co-
administration of DMSA with MiADMSA has been found
more effective than mono-therapy with MiADMSA, not
only in controlling lipid peroxidation but also in control-
ling decreased catalase activity. It helps to reduce the dose
of chelator agent, provides better clinical recoveries and
minimize the possible side effects [81,87].
Plasma exchange-hemodialysis-plasmapheresis
Plasma exchange is initiated about 24-36 hours after the
clinical diagnosis, when the patient’s life is in danger and
there is no suitable alternative therapy. Plasma exchange
may be used in emergency condition, if there is a high
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fore, plasma exchange can potentially be useful in heavy
metals toxicity e.g. mercury [88]. Hemodialysis is the
best way for water-soluble and dialyzable substances,
also if renal failure occurs, hemodialysis maybe neces-
sary [38,89]. Some of the toxic substances can strongly
bind to plasma proteins and cannot be removed by
hemodialysis. Plasmapheresis is eventually able to re-
move protein- bound heavy metals in plasma, such as
mercury. Some toxicologists suggest using these proce-
dures with chelating agents. In mono-therapy the elim-
ination half- life of inorganic mercury may vary from 30
to100 days. When DMPS and hemodialysis are co-
administered, the elimination half-life may be decreased
between 2 to 8 days [89,90].
Managements of mercury contaminations
Natural and chemical decontamination
Algae, Azolla and other aquatic plants possess the ability
to uptake toxic agents from the environment [91,92].
Chlorella increases elimination of mercury from the GIT,
muscles, ligaments, connective tissue, and bone [93].
Chlorella and cilantro as food materials can detoxify some
neurotoxins such as heavy metals (e.g. mercury) and toxic
chemicals (e.g. phthalates, plasticizers and insecticides
[94,95]. Photoinduced electron transfer (PET) sensor has
been used for the detection of mercury ions [96]. It shows
high selectivity for mercury ions in buffer solution
(pH = 7). This sensor can selectively bind to very low
concentration Hg2+ to form stable complexes [96]. The
complexes of AgNPs with polyethylene glycol (PEG) and
polyvinylpyrrolidone (PVP) are other systems that show
high selectivity for Hg2+ [65].
Nano filtration
Nanotechnology may help to decrease water pollution
problems by removing microorganisms, pesticides, insecti-
cides and heavy metals (lead, mercury, cadmium, zinc).
Nano-catalysts and nano-filters can eliminate toxic con-
taminants from waste waters [97]. Removing mercury by
carbon nanotubes (CNTs) is an effective method in this
field. Oxidized CNTs can absorb cations, because in this
form the surface of absorption of CNTs is increased along
with chemical and electrostatic binding [98].
Finally, long term administration of nano-medicines is
still waiting to be approved by FDA and other autho-
rized international organizations. In addition, removal of
vapor-phase elemental mercury from stack emissions
with sulfur-impregnated activated carbon has been un-
der consideration.
Conclusion
Mercury exposure leads to harmful effects on almost
every organ and system. It should be considered as asilent threat to environment and human life, through
the world. The main concern is with the more subtle ef-
fects arising from prenatal to adult's period, and exist
delay development and cognitive changes in children
and clinical manifestations in adults. New protocols for
the treatment of poisoning such as access to new anti-
dotes, chelating agents, combination therapy of different
chelating agents and specific nano-sorbents can help in
the management of mercury poisoning. There are risks
of mercury compounds for health in the worldwide.
Therefore governmental and non-governmental organi-
zations need to identify highly prone people to mercury
exposure, and make sure safe food and drinking water.
In addition, it is necessary to pay attention to the safe
transport and handling of mercury compounds.
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